The Juvenile Diabetes Research Foundation and Selecta Biosciences, Inc. Enter Research Collaboration for Vaccines for Type 1 Diabetes
NEW YORK & WATERTOWN, Mass.--(BUSINESS WIRE)--The Juvenile Diabetes Research Foundation (JDRF) and Selecta Biosciences, Inc. announced today that they have established a research collaboration to support Selecta’s development of a vaccine technology, which may subsequently help to better treat and potentially prevent type 1 diabetes.